Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia
Jingyu Zhang(Hangzhou First People's Hospital), Jinxin Che(Pharmaceutical Biotechnology (Czechia)), Shenxin Zeng(Hangzhou Medical College), Wenhai Huang(Hangzhou Medical College), Nengming Lin(Westlake University), Ao Pang(Zhejiang University), Yuheng Jin(Zhejiang University), Yubo Zhou(Sichuan Mianyang 404 Hospital), Yuwei Wang(Peking University), Haiting Duan(Zhejiang University), Xiaoli Yu(Zhejiang University), Xiaojun Yao(Macau University of Science and Technology), Mingfei Wu(Zhejiang University), Jia Li(Shanghai Institute of Materia Medica), Liteng Shen(Zhejiang Lab), Renzhao Gui(Zunyi Medical University), Bo Zhang(Hangzhou First People's Hospital), Xiaowu Dong(Second Affiliated Hospital of Zhejiang University)
Cited by 14
Related Papers
Separation and Identification of Major Plant Sphingolipid Classes from Leaves
|Journal of Biological Chemistry|2006|340
Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees
|EMBO Reports|2011|207
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|198
Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases
|American Journal of Respiratory and Critical Care Medicine|2022|148
Synthesis, Modulation, and Application of Two-Dimensional TMD Heterostructures
|Chemical Reviews|2024|127